Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

Generalized Anxiety Disorder: The Worry You Thought Was Just Your Personality

Clinically reviewed by Daniel Montville, MD

Reviewed November 5, 2026 · Last updated November 5, 2026

Key Takeaways

  • About 2.7% of U.S. adults have generalized anxiety disorder in a given year, and 5.7% will have it at some point in their lives, according to NIMH.
  • GAD is diagnosed when worry is hard to control on most days for at least 6 months, along with at least three symptoms such as restlessness, fatigue, poor concentration, irritability, muscle tension, or sleep problems.
  • CBT is the gold-standard therapy for GAD, and NIMH lists SSRIs and SNRIs among effective medication options. A network meta-analysis of 89 trials found several medications effective, including duloxetine, venlafaxine, and escitalopram.
  • Most people with anxiety disorders don't get adequate care. In surveys across 21 countries, 27.6% received any treatment and only 9.8% received treatment that was possibly adequate.
  • Stopping an antidepressant that's working raises relapse risk. In relapse prevention trials, 36.4% of people switched to placebo relapsed, compared with 16.4% who stayed on medication.

You’ve been called a worrier your whole life. Your mind runs through what could go wrong at work, with your health, with the people you love, and it rarely takes a day off. At some point, you decided that’s just who you are.

Your brain is built to anticipate problems, and worry is that system running ahead of you. In generalized anxiety disorder (GAD), the system stays switched on most days for months at a time, even when nothing is wrong, and it shows up in your body as tense muscles, poor sleep, and fatigue. Good treatment works on that system with precision, targeting both the thinking patterns that keep worry going and the body’s stress response that keeps it loud.

The standard treatments are well studied. NIMH’s GAD guide describes cognitive behavioral therapy (CBT) as the gold-standard psychotherapy and lists SSRIs and SNRIs among effective medication options. A Lancet network meta-analysis of 89 trials found several medications effective. The results are real, and the science is well established.

The treatments work, but most people with anxiety disorders never get care that’s adequate, and at Siggy we don’t think a treatable condition should wait until it becomes a crisis.

Better GAD care is measured care. That means symptoms tracked on a validated scale, treatment adjusted when progress stalls, and medication continued long enough to protect the gains you’ve made. It targets the same worry cycle the standard treatments do, with closer follow-through, because the risk of relapse after stopping treatment early is a matter of evidence.

What This Page Covers

What Is Generalized Anxiety Disorder?

GAD is persistent, excessive worry about everyday things that’s hard to control and gets in the way of your life. NIMH’s GAD statistics estimate that 2.7% of U.S. adults have GAD in a given year and 5.7% experience it at some point in their lives. It’s more common in women than in men, at 3.4% versus 1.9% in a given year.

GAD isn’t a mild problem for most people who have it. In the same national survey data, 32.3% of adults with GAD had serious impairment, 44.6% had moderate impairment, and 23.1% had mild impairment.

NIMH notes that GAD develops gradually and usually starts in early adulthood, though it can begin at any age. Researchers think it comes from a mix of genetics, brain chemistry, biology, and environment, and stressful or traumatic experiences may raise the risk. Our guide to what causes anxiety goes deeper on those factors.

What Does GAD Feel Like Day to Day?

GAD lives in your body as much as your mind. Common signs NIMH describes include:

  • Worrying about everyday things and struggling to turn it off
  • Feeling restless, on edge, or irritable
  • Having a hard time concentrating
  • Trouble falling or staying asleep, or feeling tired all the time
  • Headaches, muscle aches, stomachaches, or tension
  • Sweating, trembling, lightheadedness, or feeling out of breath

The worries tend to land on ordinary things: job performance, health, money, your family’s well-being, being late, or keeping up with chores. Symptoms often rise and fall, and NIMH notes they tend to get worse during stressful stretches like an illness or a conflict at home.

If physical symptoms are what brought you here, our guide to what anxiety feels like walks through the body side in more detail.

How Is GAD Different From Everyday Worry?

Everyone worries. The difference is intensity, duration, and control. NIMH describes GAD as a persistent feeling of anxiety or dread that interferes with how you live, and it notes that GAD differs from occasional worry or anxiety tied to a stressful event. With GAD, the worry is often out of proportion to the situation, and it can last for months or years.

A simple gut check is whether the worry keeps going after the stressor is gone, or whether it jumps from one topic to the next without a clear trigger. Another is whether it’s costing you sleep, focus, or time with people you care about.

GAD also rarely travels alone. NIMH lists depression, other anxiety disorders, PTSD, chronic pain, and alcohol or substance misuse among the conditions that commonly occur alongside it. When more than one condition is present, treatment works best when it addresses the whole picture.

How Is GAD Diagnosed?

A clinician diagnoses GAD based on your history and symptoms. According to NIMH, you have to find worry hard to control on most days for at least 6 months, along with at least three of these: restlessness or feeling on edge, fatigue, trouble concentrating, irritability, muscle tension, or sleep problems. A provider will usually ask when symptoms started, how often they happen, and how they affect your life, and may do a physical exam to rule out other causes.

Screening questionnaires help start that conversation, and one widely used tool is the GAD-7. In the original GAD-7 validation study, conducted in 15 primary care clinics, the scale’s best cut point correctly identified 89% of people with GAD and correctly ruled out 82% of people without it. Higher scores were strongly linked with problems in daily functioning.

Screening is now recommended in routine care. The USPSTF’s 2023 recommendation calls for screening adults for anxiety disorders, including during pregnancy and after giving birth. It found the evidence insufficient to weigh benefits and harms for adults 65 and older. If you want to know what to expect from the process, our guide to getting diagnosed with anxiety covers the steps.

Which Treatments Work for GAD?

GAD usually responds to therapy, medication, or both, and NIMH notes that finding the right fit can take some trial and error.

On the therapy side, NIMH describes CBT as the gold standard for GAD and acceptance and commitment therapy (ACT) as a growing option. In a placebo-controlled meta-analysis of CBT for anxiety, the effect for GAD was large. Our guide to cognitive behavioral therapy explains how sessions work.

On the medication side, NIMH lists several options. Here’s how the main types compare, based on NIMH’s guidance:

Medication Type Examples How Fast It Helps Key Tradeoffs
SSRIs Escitalopram, sertraline Several weeks Headaches, nausea, sleep changes
SNRIs Duloxetine, venlafaxine Several weeks Similar early side effects
Buspirone Buspirone 3 to 4 weeks for full effect Not sedating, lower addiction potential
Benzodiazepines Lorazepam, alprazolam Rapid Tolerance and dependence, short-term use

The Lancet network meta-analysis included 25,441 patients. Duloxetine, venlafaxine, and escitalopram were more effective than placebo with relatively good tolerability, and sertraline and buspirone also looked effective in smaller samples. Its authors concluded that if a first medication doesn’t work, that isn’t a reason to give up on medication as a strategy. Our guide to the best anxiety medication compares the options in more depth.

Why Does Staying With Treatment Matter So Much?

Getting treatment at all is the first hurdle. The World Mental Health Surveys covered 51,547 people in 21 countries. Among those with an anxiety disorder in the past year, only 27.6% received any treatment and just 9.8% received treatment that met a basic adequacy standard.

Staying with treatment is the second hurdle. GAD tends to be long-lasting, and stopping an effective medication too early carries real risk. In a BMJ meta-analysis of 28 relapse prevention trials with 5,233 patients, people who responded to an antidepressant and were then switched to placebo relapsed 36.4% of the time, compared with 16.4% of those who stayed on medication. Stopping roughly tripled the odds of relapse within the first year.

That’s why the moment you start feeling better is an important one. Feeling better is a sign treatment is working, and a prescriber can help you decide whether and when to taper, slowly and with a plan. Our guide to how long anxiety medication takes to work covers the early weeks.

What Helps Between Appointments?

Daily habits won’t replace treatment, but they can make it work better. NIMH notes that cutting back on caffeine and getting enough sleep can reduce anxiety symptoms when paired with standard care, and that exercise, mindfulness, and meditation can reduce symptoms and boost the effects of therapy.

A few practical places to start:

  • Keep a short worry log so you can see patterns and bring them to your clinician
  • Move your body most days, even for a short walk
  • Protect a consistent sleep and wake time
  • Notice how caffeine and alcohol affect your anxiety the next day

When a wave of anxiety hits, our guide to calming anxiety in the moment has techniques you can use right away.

How Siggy Fits In

Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, and GAD is one of the most common. The anonymous intake needs no name, email, or account, which can make it easier to describe worries you haven’t said out loud before.

After intake, you get a downloadable summary you can keep or share with any clinician. If medication may help, a licensed prescriber reviews your full intake before anything is prescribed, and the plan reflects what you shared. Siggy combines human clinicians with AI therapy and daily check-ins, and you can use it alongside CBT if you’re already working with a therapist.

Siggy isn’t an emergency service. If you’re in crisis or thinking about suicide, call or text 988, or call 911 in a life-threatening situation. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.

Find Out What Your Worry Is Telling You

GAD is common and treatable, and the people who do best are the ones whose care keeps going after the first prescription or the first few therapy sessions. If you’ve wondered whether your worry is more than a personality trait, our guide to the difference between stress and anxiety is a good place to compare what you’re feeling. Start your anonymous intake and describe your worries, sleep, and energy in your own words. It’s free, a real doctor reviews every clinical decision, and the summary is yours to share with whoever helps you next.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

What is the main symptom of generalized anxiety disorder?

The main symptom of generalized anxiety disorder is excessive worry about everyday things that is hard to control and happens on most days for at least 6 months. According to NIMH, it comes with at least three other symptoms, such as feeling restless or on edge, fatigue, trouble concentrating, irritability, muscle tension, or sleep problems.

How is GAD different from normal worry?

Normal worry comes and goes with real stressors, while GAD involves persistent anxiety or dread that is out of proportion to the situation and interferes with daily life. NIMH notes that GAD feelings can last for months or even years, which separates it from occasional worry about a stressful event.

What is the GAD-7?

The GAD-7 is a seven-question self-report scale used to screen for generalized anxiety disorder and measure its severity. In the original validation study in primary care, its best cut point correctly identified 89% of people with GAD and correctly ruled out 82% of people without it. A screening score is not a diagnosis, so a clinician confirms the result.

What is the best medication for generalized anxiety disorder?

There isn't one best medication for everyone. NIMH lists SSRIs and SNRIs among the medication types that can be effective for GAD. A 2019 network meta-analysis of 89 trials found duloxetine, venlafaxine, and escitalopram effective with relatively good tolerability. The right choice depends on your symptoms, other conditions, side effect concerns, and history, so it should be made with a prescriber.

Can generalized anxiety disorder go away on its own?

GAD can last a long time, so it's worth getting evaluated rather than waiting it out. NIMH notes that anxiety feelings in GAD can last for months or even years and that symptoms often get worse during stressful periods. With the right treatment and support, NIMH says people with GAD can manage their anxiety and improve their quality of life.

How long should I stay on medication for GAD?

Most people benefit from staying on an effective medication for a while after they feel better, and the timing should be decided with a prescriber. A meta-analysis of 28 relapse prevention trials found that stopping antidepressants within the first year roughly tripled the odds of relapse compared with continuing them. Never stop suddenly without guidance.

Sources

  1. National Institute of Mental Health. Generalized Anxiety Disorder: What You Need to Know. Revised 2025. nimh.nih.gov
  2. National Institute of Mental Health. Generalized anxiety disorder statistics. nimh.nih.gov
  3. Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019;393(10173):768-777. doi:10.1016/S0140-6736(18)31793-8
  4. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine. 2006;166(10):1092-1097. doi:10.1001/archinte.166.10.1092
  5. US Preventive Services Task Force. Screening for anxiety disorders in adults: US Preventive Services Task Force recommendation statement. JAMA. 2023;329(24):2163-2170. doi:10.1001/jama.2023.9301
  6. Carpenter JK, Andrews LA, Witcraft SM, Powers MB, Smits JAJ, Hofmann SG. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depression and Anxiety. 2018;35(6):502-514. doi:10.1002/da.22728
  7. Alonso J, Liu Z, Evans-Lacko S, et al. Treatment gap for anxiety disorders is global: results of the World Mental Health Surveys in 21 countries. Depression and Anxiety. 2018;35(3):195-208. doi:10.1002/da.22711
  8. Batelaan NM, Bosman RC, Muntingh A, Scholten W, Huijbregts KML, van Balkom AJLM. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ. 2017;358:j3927. doi:10.1136/bmj.j3927